Viewing nowCombinationOlmesartan Medoxomil 20/5 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202003958 · Approved 2020.05.28
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression and cardiovascular disease risk
This medication contains both Olmesartan Medoxomil and Rosuvastatin and is used for specific patients. Olmesartan Medoxomil helps in treating essential hypertension. Meanwhile, Rosuvastatin is used as an adjunct in patients with hypercholesterolemia and dyslipidemia when diet and exercise are insufficient. It also aids in the treatment of familial hypercholesterolemia or dysbetalipoproteinemia, reducing total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis. This medication is also used to reduce cardiovascular disease risk in men over 50 and women over 60 who are at high risk due to elevated high-sensitivity C-reactive protein levels, minimizing the risk of stroke, myocardial infarction, and arterial revascularization. Therefore, it is effective for managing blood pressure and cholesterol and reducing cardiovascular disease risk.
This medicine is administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil and rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that this medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. 2. Elderly patients No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients. ◆ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5mg once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10mg once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20mg once daily. 2. Elderly patients No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5mg. Administration of the 40mg dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5mg. Administration of the 40mg dose of this medicine is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
The safety and efficacy in children under 18 years of age have not been established.
This medication can cause serious damage to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Persons who are allergic to this medication or its components, pregnant or potentially pregnant women, and breastfeeding individuals should not take this medication. Patients with severely impaired kidney function, those on dialysis, patients with severe liver impairment, patients with biliary obstruction, and those with muscle diseases should not use this medication. This medication contains lactose, so individuals with lactose intolerance or related genetic conditions should avoid it. Patients with reduced blood volume or those on high-dose diuretics should be cautious as hypotension may occur, and their condition should be well monitored in the early stages of treatment. While taking this medication, regular monitoring of blood pressure, kidney function, blood potassium levels, etc., is necessary to ensure there are no abnormalities. This medication may cause myalgia or muscle weakness, and rarely, it may lead to rhabdomyolysis, so consultation with a doctor should be sought immediately if there is muscle pain or weakness. Elderly patients or those with a history of liver disease should have their liver function tested regularly and should avoid alcohol consumption. This medication may interact with other drugs, so it is essential to inform healthcare providers if other medications are being taken. Dizziness or drowsiness may occur during treatment, so caution should be exercised while driving or handling dangerous machinery. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should use appropriate contraception. Safety and efficacy in children or adolescents under 18 have not been established. In cases of overdose, hypotension or arrhythmia may occur, so immediate medical attention is necessary, and there is no specific antidote. This medication should be kept out of reach of children and should not be transferred to other containers.
Increased ALT, increased AST, elevated blood creatinine, decreased creatinine clearance, headache, dizziness, decreased sensation, neuromyopathy, drowsiness, gastroesophageal reflux disease, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal stiffness, atrial fibrillation, hypoglycemia, chest pain, tooth extraction, breast pain, peripheral edema, vertigo, abdominal pain, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial swelling, weakness, vascular edema, anaphylactic reaction, vomiting, chronic malabsorption syndrome, intestinal vascular edema, rhabdomyolysis, hyperkalemia, acute renal failure, alopecia, pruritus, urticaria, autoimmune hepatitis, dizziness (including positional vertigo), palpitations, elevated blood pressure, low back pain, increased blood creatinine, diarrhea, cough, epistaxis, upper respiratory tract infection, asthma, hypersensitivity reaction including vascular edema, diabetes, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, dyspnea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia gravis, ocular myasthenia gravis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White or slightly yellow round film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.